参考文献/References:
[1] Ter Telgte A,Van Leijsen EM,Wiegertjes K,et al.Cerebral small vessel disease: from a focal to a global perspective[J].Nat Rev Neurol,2018,14(7):387-398.
[2] 中华医学会神经病学分会.中华医学会神经病学分会脑血管病学组.中国脑小血管病诊治共识[J].中华神经科杂志,2015,48(10):838-844.
[3] Si J,Li K,Shan P,et al.The combined presence of hypertension and vitamin D deficiency increased the probability of the occurrence of small vessel disease in China[J].BMC Neurol,2019,19(1):164.
[4] Wardlaw JM,Smith EE,Biessels GJ,et al.Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration[J].The Lancet Neurology,2013,12(8):822-838.
[5] 黄勇华,赵弘轶.脑小血管病研究新理念[J].中国现代神经疾病杂志,2019,19(07):461-465.
[6] Wang N,Allali G,Kesavadas C,et al.Cerebral small vessel disease and motoric cognitive risk syndrome: results from the Kerala-Einstein study[J].Journal of Alzheimers Disease,2016,50(3):699-707.
[7] Webster KE,Wittwer JE,Feller JA.Validity of the GAITRite(R)walkway system for the measurement of averaged and individual step parameters of gait[J].Gait Posture,2005,22(4):317-321.
[8] Choi P,Ren M,Phan TG,et al.Silent infarcts and cerebral microbleeds modify the associations of white matter lesions with gait and postural stability Population-Based study[J].Stroke,2012,43(6):1505-1510.
[9] Cannistraro RJ,Badi M,Eidelman BH,et al.CNS small vessel disease A clinical review[J].Neurology,2019,92(24):1146-1156.
[10] Tabara Y,Okada Y,Ohara M,et al.Association of postural instability with asymptomatic cerebrovascular damage and cognitive decline:Japan Shimanami Health Promoting Program Study[J].Stroke,2015,46(1):16-22.
[11] Wardlaw JM,Smith C,Dichgans M,et al.Small vessel disease: mechanisms and clinical implications[J].Lancet Neurol,2019,18(7):684-696.
[12] Fazekas F,Barkhof F,Wahlund LO,et al.CT and MRI rating of white matter lesions[J].Cerebrovasc Dis,2002,13(Suppl2):31-36.
[13] Smith EE,O'donnell M,Dagenais G,et al.Early cerebral small vessel disease and brain volume, cognition, and gait[J].Ann Neurol,2015,77(2):251-261.
[14] Toda K,Iijima M,Kitagawa K,et al.Periventricular white matter lesions influence gait functions in parkinson's disease[J].Eur Neurol,2019,81(3/4):120-127.
[15] Scheltens PM Bavkhof F,Leys D, et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging[J].Neurol Sci,1993,114(1):7-12.
[16] Van der Holst HM,Tuladhar AM,Zerbi V,et al.White matter changes and gait decline in cerebral small vessel disease[J].Neuroimage Clin,2017,17:731-738.
[17] Li Y,Qiu L.Characteristics of balance disorders in patients with white matter hyperintensities[J].Chin J Contemp Neurol Neurosurg,2019,19(07):496-500.
[18] Shibata K,Sugiura M,Nishimura Y,et al.The effect of small vessel disease on motor and cognitive function in Parkinson's disease[J].Clin Neurol Neurosurg,2019,182(2019):58-62.
[19] Fénelon G,Gray F,Wallays C,et al.Parkinsonism and dilatation of the perivascular spaces(état criblé)of the striatum:a clinical, magnetic resonance imaging,and pathological study[J].Mov Disord,1995,10(6):754-760.
[20] Weller RO,Hawkes CA,Kalaria RN,et al.White matter changes in dementia:role of impaired drainage of interstitial fluid[J].Brain Pathol,2015,25(1):63-78.
[21] Wennberg AM,Lesnick TG,Schwarz CG,et al.Longitudinal association between brain Amyloid-Beta and gait in the Mayo clinic study of aging[J].Journals of Gerontology Series A - Biological Sciences and Medical Sciences,2018,73(9):1244-1250.
[22] Low A,Mak E,Rowe JB,et al.Inflammation and cerebral small vessel disease: A systematic review[J].Ageing Res Rev,2019,53(2019):100916.
[23] Cheng AL,Batool S,Mccreary CR,et al.Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds[J].Stroke,2013,44(10):2782-2786.
[24] De Laat KF,Van Den Berg HA,Van Norden AG,et al.Microbleeds are independently related to gait disturbances in elderly individuals with cerebral small vessel disease[J].Stroke,2011,42(2):494-497.
[25] Chiu WT,Chan L,Wu D,et al.Cerebral microbleeds are associated with postural instability and gait disturbance subtype in People with parkinson's disease[J].Eur Neurol,2018,80(5/6):335-340.
[26] Rosano C,Sigurdsson S,Siggeirsdottir K,et al.Magnetization transfer imaging,white matter hyperintensities,brain atrophy and slower gait in older men and women[J].Neurobiol Aging,2010,31(7):1197-1204.
[27] Callisaya ML,Beare R,Phan TG,et al.Global and regional associations of smaller cerebral gray and white matter volumes with gait in older People[J].PLoS One,2014,9(1):e84909.
[28] Su N,Liang XY,Zhai FF,et al.The consequence of cerebral small vessel disease: Linking brain atrophy to motor impairment in the elderly[J].Hum Brain Mapp,2018,39(11):4452-4461.
[29] Tian Q,Resnick SM,Davatzikos C,et al.A prospective study of focal brain atrophy, mobility and fitness[J].J Intern Med,2019,286(1):88-100.
[30] Smith EE,Schneider JA,Wardlaw JM,et al.Cerebral microinfarcts: the invisible lesions[J].The Lancet Neurology,2012,11(3):272-282.
[31] Kim YJ,Kwon HK,Lee JM,et al.Gray and white matter changes linking cerebral small vessel disease to gait disturbances[J].Neurology,2016,86(13):1199-1207.
[32] Patel P,Lamar M,Bhatt T,et al.Effect of type of cognitive task and walking speed on cognitivemotor interference during dual-task walking[J].Neuroscience,2014,260(2014):140-148.
[33] Ungvari Z,Tarantini S,Kirkpatrick AC,et al.Cerebral microhemorrhages: mechanisms, Consequences, and prevention[J].Am J Physiol Heart Circ Physiol,2017,312(6):H1128-H1143.
[34] Fujishima M,Maikusa N,Nakamura K,et al.Mild cognitive impairment, poor episodic memory, and late-life depression are associated with cerebral cortical thinning and increased white matter hyperintensities[J/OL].Front Aging Neurosci,2014,6(2014):306.
[35] Kubota M,Iijima M,Shirai Y,et al.Association between cerebral small vessel disease and central motor conduction time in patients with vascular risk[J].Journal of Stroke & Cerebrovascular Diseases,2019,28(8):2343-2350.
[36] Grool AM,Gerritsen L,Zuithoff,et al.Lacunar infarcts in deep white matter are associated with higher and more fluctuating depressive symptoms during three years followup[J].Biol Psychiatry,2013,73(2):169-176.